Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. ICL Group Ltd
  6. News
  7. Summary
    ICL   IL0002810146

ICL GROUP LTD

(ICL)
  Report
End-of-day quote TEL AVIV STOCK EXCHANGE  -  2022-08-17
32.79 ILS   +0.49%
08/17ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products - Evogene
AQ
08/16ICL Group to Work With Evogene's Lavie Bio Unit to Develop Novel Bio-Stimulant Products
MT
08/16ICL Group Ltd and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ICL Group Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022

05/11/2022 | 06:01am EDT
share with twitter
share with LinkedIn
share with facebook

ICL Group Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 2,525 million compared to USD 1,510 million a year ago. Net income was USD 632 million compared to USD 135 million a year ago. Basic earnings per share from continuing operations was USD 0.49 compared to USD 0.11 a year ago. Diluted earnings per share from continuing operations was USD 0.49 compared to USD 0.11 a year ago.


© S&P Capital IQ 2022
All news about ICL GROUP LTD
08/17ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products..
AQ
08/16ICL Group to Work With Evogene's Lavie Bio Unit to Develop Novel Bio-Stimulant Products
MT
08/16ICL Group Ltd and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulan..
CI
08/16ADDING MULTIMEDIA ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-..
BU
08/11ICL : Other Report or Announcement
PU
08/11ICL Group Ltd Signs Binding Memorandum of Understanding with A European Customer, to Su..
CI
08/03ICL to Participate in Fireside Chat at Jefferies Industrials Conference
BU
07/28BMO Capital Adjusts Price Target on ICL Group to $11 From $12, Maintains Market Perform..
MT
07/27TRANSCRIPT : ICL Group Ltd, Q2 2022 Earnings Call, Jul 27, 2022
CI
07/27ICL : INCORPORATION BY REFERENCE - Form 6-K
PU
More news
Analyst Recommendations on ICL GROUP LTD
More recommendations
Financials (USD)
Sales 2022 10 499 M - -
Net income 2022 2 257 M - -
Net Debt 2022 1 865 M - -
P/E ratio 2022 5,78x
Yield 2022 9,04%
Capitalization 13 005 M 12 892 M -
EV / Sales 2022 1,42x
EV / Sales 2023 1,60x
Nbr of Employees 12 000
Free-Float 52,5%
Chart ICL GROUP LTD
Duration : Period :
ICL Group Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ICL GROUP LTD
Short TermMid-TermLong Term
TrendsNeutralBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 10,10 $
Average target price 10,52 $
Spread / Average Target 4,07%
EPS Revisions
Managers and Directors
Raviv Zoller President & Chief Executive Officer
Aviram Lahav Chief Financial Officer
Yoav Doppelt Executive Chairman
Miri Mishor Executive Vice President-Information Technology
Anantha N. Desikan Chief Research, Development & Innovation Officer
Sector and Competitors
1st jan.Capi. (M$)
ICL GROUP LTD9.26%12 892
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.78.60%26 856
PHOSAGRO35.93%17 143
UPL LIMITED2.79%7 289
YUNNAN YUNTIANHUA CO., LTD.33.28%7 137
PI INDUSTRIES LIMITED9.47%6 512